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A NORMALLY RISING HCG DOES NOT PREDICT LIVE BIRTH IN
WOMEN PRESENTING WITH PAIN AND BLEEDING IN EARLY
PREGNANCY
Andrew W Horne1, Rosslyn McBride1, and Fiona C Denison1,*
1Centre for Reproductive Biology, University of Edinburgh, 47 Little France Crescent, Edinburgh,
EH16 4TJ
Dear Editor,
We have undertaken a retrospective cohort study to determine whether, in women who
present with pain and bleeding in early pregnancy, serial human chorionic gonadotrophin
(hCG) levels can be used to predict progress beyond the first trimester. We hypothesised that
a normally rising hCG would predict live birth in women presenting with pain and bleeding
in early pregnancy.
The study group consisted of 340 women who presented with pain and/or bleeding at <12
weeks gestation and who had an inconclusive ultrasound scan at their first visit to the
Pregnancy Support Centre. The mean (+/−SD) age and median parity (range) of the cohort
were 30 (+/−6.5) and P0 (0 – 5), respectively. 19% (64/340) were current smokers. All
women were monitored with serial hCGs (defined as two hCGs taken 48hrs apart) to
exclude ectopic pregnancy. Pregnancies were categorised by the percentage change in the
first two hCG measurements taken 48hrs apart: ‘normally rising’ (≥66%), ‘slowly rising’
(increase of <66% but >10%), ‘static’ (increase or decrease ≤10%) or ‘falling’ (≥10%).
Pregnancy outcome was recorded as livebirth, miscarriage, ectopic pregnancy and
pregnancy of unknown location. Data were analysed descriptively using GraphPad Prism
(version 5.0). Confidence intervals for percentages were calculated by Wilsons method.
The proportion of pregnancies with ‘normally rising’, ‘slowly rising’, ‘static’ and ‘falling’
hCGs was 18.5% (63/340), 12.4% (42/340), 6.2% (21/340), 62.9% (214/340), respectively.
There were no significant differences in maternal characteristics (age, parity, smoking
status) between groups identified (data not shown). The pregnancy outcomes for each hCG
group are shown in Table 1. As expected, no pregnancies with ‘falling’ or ‘static’
measurements continued beyond the first trimester. However, we were surprised to find only
57% (36/63) women with ‘normally rising’ measurements had a live birth. Two women
(4.8%, 2/42) with ‘slowly rising’ hCGs also had a live birth.
To our knowledge, this is the largest study to date that has related serial serum hCG profiles
in women presenting with pain and/or bleeding in the first trimester of pregnancy to live
birth.
Our finding that only 57% of women with ‘normally rising’ hCGs went on to have live birth
is lower than a similar but much smaller study claiming a livebirth rate of 81.6%. [1]
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However, this study examined a population of asymptomatic infertile patients who had
undergone a variety of fertility treatments to achieve pregnancy. This compared to our study
population that consisted of women who conceived spontaneously and subsequently
presented with pain and / or bleeding in the first trimester. Thus, it is clear that a ‘normally
rising’ hCG profile is no guarantee of a live birth in women who present with pain and/or
bleeding in the first trimester of pregnancy after spontaneous conception.
We were also surprised to find that two women with ‘slowly rising’ hCGs subsequently
went on to have a live birth. This conflicts with previously published data that showed that a
‘slowly rising’ hCG was not associated with continuation beyond the first trimester, even
when fetal heart activity had been demonstrated on ultrasound. [1]
Thus we conclude that, contrary to our hypothesis, a ‘normally rising’ hCG should not be
used to reassure women and predict livebirth in women presenting with pain and / or
bleeding in early pregnancy. We suggest that further studies are required to develop novel
biomarkers to predict and diagnose pregnancy outcome and location in women who present
with pain and bleeding in early pregnancy. [2]
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Table 1
Pregnancy outcome for each hCG group.
hCG group Pregnancy outcome
Livebirth Miscarriage Ectopic Pregnancy
unknown location
Normally rising
(n=63)
36 (57%) 17 (27%) 10 (16%) 0
Slowly rising
(n=42)
2 (5%) 18 (43%) 18 (43%) 4 (9%)
Static
(n=21)
0 6 (29%) 11 (52%) 4 (19%)
Falling
(n=214)
0 196 (92%) 6 (3%) 12 (6%)
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